In a historic move, the World Health Organization has launched its inaugural clinical trial for an Ebola vaccine in the Democratic Republic of Congo. This trial aims to assess the efficacy of the Ervebo vaccine against the Bundibugyo virus amid a severe outbreak that has resulted in over 9,700 cases and 4,600 fatalities since May.
Trending
- ‘Give priority to local artisans’: PM Modi’s festive shopping appeal as Diwali approaches
- ‘JD(U) is finished’: Bihar strongman Anant Singh to float own party after expulsion
- Five IPOs to hit Dalal Street next week, targeting nearly Rs 2,600 cr from investors
- Bill Kaulitz renovates Lloyd Wright-designed Hollywood Hills home after water damage
- Ukraine drone attacks kill three, injure 14 in Russia’s Belgorod region
- ‘When will you score runs?’ Babar Azam’s weaknesses exposed by ex-Pakistan player
- Drone attack: Iran targets Kurdish opposition bases in Iraq
- Trump claims US has secured Greenland, Venezuela in ‘greatest real estate deal’
Tumaini Trial Launch: WHO begins Ebola vaccine study in DRC; aims to protect against Bundibugyo strain
By
Add A Comment